Nektar Therapeutics
NKTR
#4051
Rank
โ‚ฌ2.59 B
Marketcap
78,18ย โ‚ฌ
Share price
0.46%
Change (1 day)
658.00%
Change (1 year)

Revenue for Nektar Therapeutics (NKTR)

Revenue in 2025 (TTM): โ‚ฌ47.75 Million

According to Nektar Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ47.1 Million. a decrease over the revenue in the year 2024 that were of โ‚ฌ94.58 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Nektar Therapeutics from 1996 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ47.01 M-50.29%
2024 โ‚ฌ94.58 M16.02%
2023 โ‚ฌ81.52 M-5%
2022 โ‚ฌ85.81 M-4.63%
2021 โ‚ฌ89.98 M-27.62%
2020 โ‚ฌ0.12 B21.51%
2019 โ‚ฌ0.10 B-90.19%
2018 โ‚ฌ1.04 B306.74%
2017 โ‚ฌ0.25 B63.05%
2016 โ‚ฌ0.15 B-25.48%
2015 โ‚ฌ0.21 B27.9%
2014 โ‚ฌ0.16 B53.04%
2013 โ‚ฌ0.10 B75.69%
2012 โ‚ฌ61.37 M11.51%
2011 โ‚ฌ55.04 M-53.97%
2010 โ‚ฌ0.11 B138.15%
2009 โ‚ฌ50.2 M-22.17%
2008 โ‚ฌ64.51 M-65.5%
2007 โ‚ฌ0.18 B13.33%
2006 โ‚ฌ0.16 B54.78%
2005 โ‚ฌ0.10 B26.55%
2004 โ‚ฌ84.23 M-0.19%
2003 โ‚ฌ84.39 M-6.98%
2002 โ‚ฌ90.73 M3.43%
2001 โ‚ฌ87.71 M60.06%
2000 โ‚ฌ54.8 M33.27%
1999 โ‚ฌ41.12 M123.73%
1998 โ‚ฌ18.38 M34.24%
1997 โ‚ฌ13.69 M135.49%
1996 โ‚ฌ5.81 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ80.32 B 170,440.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.36 B 113,202.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ31.34 B 66,439.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ9.58 B 20,257.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ55.44 B 117,605.32%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ50.09 B 106,249.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚ฌ0.18 B 284.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚ฌ1.25 B 2,572.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland